The Prognostic Role of Interferon Gamma-inducible Protein 30 in ClearCell Renal Cell Carcinoma with Immune Infiltrates
IFI30 is a prognostic biomarker for ccRCC patients. Targeting IFI30 may provide new strategies for cancer therapy and improve the prognosis of ccRCC patients.
Authors
- T.‐C. Wu (ORCID: https://orcid.org/0000-0003-1623-4584)
- Tao Wang (ORCID: https://orcid.org/0000-0001-8690-6097)
- Dawei Liu (ORCID: https://orcid.org/0000-0003-1911-9207)
- Yufeng Liu (ORCID: https://orcid.org/0000-0002-9472-9104)
- Qing Li (ORCID: https://orcid.org/0000-0002-5938-9167)
- Lingfei Yan
- Yang Luo (ORCID: https://orcid.org/0000-0002-5501-9935)
- Xu Wu
Institutions
- Third Affiliated Hospital of Southern Medical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Recent Patents on Anti-Cancer Drug Discovery
- Published
- 2025-02-06
- DOI
- https://doi.org/10.2174/0115748928367598250124123411
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05